HRT FINANCIAL LP

Position in MRK — Merck & Co., Inc.

CIK 1475597 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$102,549,168

+$85,380,297 QoQ

Shares Held

798,048

+459.1% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#211

of 3,778 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names. MRK ranks #3 (14.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,031,961	$262,087,135
2	ABBV	AbbVie Inc.	702,907	$176,879,517
3	MRK	Merck & Co., Inc. This page	798,048	$102,549,168
4	LLY	ELI LILLY & Co	38,616	$46,317,192
5	BMY	Bristol Myers Squibb Co	741,187	$42,707,194
6	GSK	GSK plc	603,902	$31,656,542
7	NVS	Novartis AG	89,587	$14,040,074
8	NVO	Novo Nordisk A S	148,940	$7,140,183

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$102,549,168	798,048	+459.1%	Shares	Defined	2026-08-14
2026-03-31	$17,168,871	142,729	-76.7%	Shares	Defined	2026-05-14
2025-12-31	$64,498,696	612,756	+137.4%	Shares	Defined	2026-02-12
2025-09-30	$21,658,891	258,059	-76.8%	Shares	Defined	2025-11-14
2025-06-30	$88,220,099	1,114,453	-29.4%	Shares	Defined	2025-08-14
2024-03-31	$208,216,044	1,577,992	+8951.2%	Shares	Defined	2024-05-13
2023-12-31	$1,900,654	17,434	-77.2%	Shares	Defined	2024-02-09
2023-09-30	$7,855,187	76,301	-39.0%	Shares	Defined	2023-11-13
2022-12-31	$13,869,082	125,003	+127.9%	Shares	Defined	2023-02-10
2022-03-31	$4,501,345	54,861	-96.9%	Shares	Defined	2022-05-16
2021-09-30	$134,357,293	1,788,807	+144.9%	Shares	Defined	2021-11-15
2021-06-30	$56,800,174	730,361	+753.1%	Shares	Defined	2021-08-16
2020-12-31	$7,003,385	85,616	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.